Abstract: Provided is a composition containing Lactobacillus reuteri ELF corresponding to a novel lactic acid bacteria strain and 5-aminolevulinic acid. The composition may be significantly effective to prevent and treat degenerative brain disease and have excellent anti-obesity and anti-diabetes effects, such that the present invention may provide various pharmaceutical composition, health foods, and the like, using the same.
Type:
Grant
Filed:
September 12, 2017
Date of Patent:
March 17, 2020
Assignee:
WEDEA INC.
Inventors:
Su Yeon Jo, Se Hyeok Min, Seok Jin Yun, Do Hee Kim